The street didn't like the released updated guidance two or so days ago. Credit Suisse came out today and said they thought the guidance was too conservative and maintained outperform and raised price target from $44 to $48.
I own TRGP too because I thought best value in MLP GPs and wanted to own one of them. CS increased annual distribution growth to 21% for TRGP and maintained outperform and increased price target from $57 to $60.
In retrospect, it would have been even sweeter for NGLS holders if the GP could have been bought out before going public.